This is a working overview of Adsorption, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-05-12 and is reviewed periodically as new material appears.
Once a peptide is dissolved, its solution is generally less stable than the dry powder. Chemical pathways such as hydrolysis, oxidation, and deamidation can alter the molecule, while physical processes can form aggregates or cause adsorption to container walls. The rate depends on pH, buffer composition, temperature, concentration, and the specific sequence. Aqueous stocks are therefore kept cold and used within a defined period. Stability testing is usually performed for each peptide rather than assumed from a general rule.
Cold storage slows most degradation but does not stop it. Reconstituted solutions are commonly divided into aliquots and held at -20 °C or -80 °C, depending on the peptide. Repeated freeze-thaw cycles can promote aggregation or precipitation, so single-use aliquots are preferred. Some peptides tolerate refrigeration for short intervals, while others require freezing immediately. Light-sensitive residues may need amber or foil-wrapped containers. The optimal condition remains peptide-specific and should be supported by stability data.
Once a peptide is in solution, its stability depends on temperature, pH, ionic strength, and the presence of oxygen or light. Many peptides are less stable in liquid form than as dry powders because hydrolysis, oxidation, and aggregation can proceed faster in water. Storage at low temperature slows these reactions but does not eliminate them. Some sequences are particularly sensitive to repeated freezing and thawing, which can cause precipitation or conformational changes. The container material and headspace also influence adsorption and surface-induced aggregation.
Practical handling often includes dividing a reconstituted solution into single-use aliquots to limit freeze-thaw cycling. Vials made of low-binding plastic or glass with inert closures are common, and some protocols add a carrier protein or bulking agent to reduce adsorption. Filtration through a sterile filter may be used when a sterile solution is required, but filters can retain peptide if binding occurs. Mixing is usually gentle; vigorous vortexing can introduce air-liquid interfaces that promote aggregation. Each of these steps involves trade-offs between sterility, recovery, and analytical accuracy.
| Property | Value | Notes |
|---|---|---|
| Storage temperature (reconstituted) | -20 °C to -80 °C | Exact condition depends on peptide, solvent, and stability data |
| Freeze-thaw stability | Limited number of cycles | Repeated cycles can increase aggregation and precipitation |
| Common degradation pathways | Hydrolysis, oxidation, deamidation | Relative rates depend on sequence, pH, and buffer |
| Container material | Low-binding polypropylene | Reduces adsorption loss for some peptides |
| Analytical method for stability | Reverse-phase HPLC | Monitors main peak loss and formation of impurity peaks |
After a dried peptide is dissolved, the resulting solution is treated as a distinct material with its own stability profile. Temperature, pH, ionic strength, and peptide concentration all influence how long the solution remains suitable for its intended laboratory use. Some sequences are prone to oxidation, deamidation, or aggregation. Because these processes vary widely, no single storage condition applies to every peptide. Buffer composition and light exposure can also shift degradation rates.
Aseptic technique matters when the solution will contact cells or biological reagents. Working in a clean environment, using sterile liquids and containers, and minimizing open-vial time reduce the chance of microbial contamination. Filtration through a sterile filter can remove particles and microorganisms, but some filters adsorb peptides and some peptides are retained by certain membrane materials. Compatibility between the peptide, solvent, and filter should be checked when recovery is critical.
Concentration calculations depend on the amount of peptide present in the vial and the volume of solvent added. Lyophilized preparations often contain counterions, salts, or residual water, so the labeled mass may not equal the mass of the peptide itself. This difference can produce a calculated concentration that is higher than the true peptide concentration. Analytical determination of peptide content, rather than reliance on the vial label alone, reduces this source of error. Uncertainty in volume measurement also contributes, especially when small liquid volumes are handled.
Quality records typically include a certificate of analysis, batch number, molecular weight, purity result, and recommended storage conditions. After reconstitution, a laboratory log may record solvent, final volume, date, and storage location. Such documentation supports reproducibility and allows later investigation if a preparation behaves unexpectedly. Stability studies often examine purity and concentration over time under defined temperatures, but results are not universally transferable between peptides or formulations. Open questions remain about how best to predict aggregation for specific sequences and how much analytical testing is sufficient for routine laboratory work.
=== Other uses in mathematics, science, and technology === Cauchy–Riemann equations, partial differential equations describing complex differentiability CR manifold, a type of differentiable manifold Chromium, symbol Cr, a chemical element Cr or CR, an improper designation given to astronomical objects in the Collinder catalog of open clusters from Collinder 1–471 Change request, a document containing a call for an adjustment of a system Compression ratio, the ratio of the volume of a combustion chamber from its largest capacity to its smallest capacity Concentration ratio, in economics Conjugate residual method, an iterative numeric method used for solving systems of linear equations Complex resistivity (measurement method), in geophysics Cosmic rays
Days after the strike had ended, the Governor Sir Tom Hickinbotham conferred with almost all of the tribal leaders from the Aden Protectorates, where broad agreement was reached that they should "seek some form of close association with each other". In May 1958 a state of emergency was declared and there were a number of bombings until the arrest of the principal instigators in July. However, in October 1958 there was a general strike, which was accompanied by widespread rioting and disorder which ended in the deportation of 240 Yemenis from Aden, as claimed by author Gillian King: "By ignoring the views of the local labour force, the British pushed much of the Arab population into opposition against their rule, who previously had been by no means captivated by Nasser". At the time much of the blame for these disturbances was placed on the broadcasts from Radio Cairo encouraged by Nasser's anti-imperialist and Arab Nationalist regime there, as claimed by author R. J. Gavin: "Radio Cairo began to speak in the tones of revolutionary Arab Nationalism. Men who had long lived in isolation now found a common political language and a breathtaking, liberating community of sentiment across the Arab world". In December 1963 there was a grenade attack by an unidentified assailant on the high commissioner who was unharmed; however, three bystanders were killed.
Shorter D-stem: To understand the role of the unusual long D-stem in tRNASec, artificial variants with shorter D-stems were put into E. coli. It turns out that these variants work faster than the standard version at regular temperatures but easily lose function at high temperatures. This suggests that the long D-stem evolved as an adaptation to high temperature. Removal of SelB and SECIS requirement: In 2013, a new kind of tRNA was artificially created by putting the acceptor stem and CUA anticodon of E. coli tRNASec on the backbone of E. coli tRNASer. This new tRNAUTu can be recognized by ordinary EF-Tu, removing the requirement for SelB and SECIS for elongation. However, about 40% of the insertions were serine instead of selenocystine, suggesting that SelA is not efficiently recognizing this tRNA. In 2014, directed evolution was used to greatly improve the ability of tRNAUTu to be recognized by SelA, achieving a version that results in no detected misincorporation of serine. This enables simple replacement of any residue by Sec in future protein engineering efforts. By 2018, the E. coli system has matured to be suitable for "industrial scale" production. In one case this was achieved by laborotaory evolution. In another case this was achieved by incorporating elements of allo-tRNAs. The tRNAUTu system was adapted to Saccharomyces cerevisiae (yeast), which has no natural selenocystine system, in 2023. A mixture of bacterial and mouse enzymes work on a modified yeast tRNASer, which is able to be recognized by eEF1A.
Sources: en.wikipedia.org
== Contents and curation == Because curation resources are finite, accession policies commonly prioritize poorly represented taxa and geographic areas, legally collected material, authoritative identifications, and specimens that can be housed and made available for study.
Newsom has also been condemned and criticized by humanitarian and queer rights organizations such as the Human Rights Campaign, National Center for LGBTQ Rights, and the Los Angeles LGBT Center. The American Civil Liberties Union issued a statement saying it was "saddened and angered" by Newsom's conduct, calling on him to "lean into his role as a leader on LGBTQ+ issues and reject the hateful, extremist rhetoric". In 2026, Newsom vetoed a bill that would have protected transgender healthcare and abortion providers from being extradited to other states. In his veto message, he said he supported protecting these services and their providers but expressed concern about the executive function of extradition.
==== Apoptosis ==== Caspases are an important group of proteases involved in apoptosis or programmed cell death. The precursors of caspase, procaspase, may be activated by proteolysis through its association with a protein complex that forms apoptosome, or by granzyme B, or via the death receptor pathways.
Sources: en.wikipedia.org
Most city residents who were exposed to the MIC gas were first made aware of the leak by exposure to the gas itself, or by opening their doors to investigate commotion, rather than having been instructed to shelter in place or to evacuate before the arrival of the gas in the first place.
Serine hydrolases are one of the largest known enzyme classes comprising approximately ~200 enzymes or 1% of the genes in the human proteome. A defining characteristic of these enzymes is the presence of a particular serine at the active site, which is used for the hydrolysis of substrates. The hydrolysis of the ester or peptide bond proceeds in two steps. First, the acyl part of the substrate (the acid part of an ester or the part of a peptide ending in a carboxyl group) is transferred to the serine, making a new ester or amide bond and releasing the other part of the substrate (the alcohol of an ester or the part of the peptide ending in an amino group) is released. Later, in a slower step, the bond between the serine and the acyl group is hydrolyzed by water or hydroxide ion, regenerating free enzyme. Unlike other, non-catalytic, serines, the reactive serine of these hydrolases is typically activated by a proton relay involving a catalytic triad consisting of the serine, an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine), although variations on this mechanism exist. Superfamilies of serine hydrolases includes:
Braegen-02 is a small-molecule drug which acts as a potent and selective agonist of the tropomyosin receptor kinase B (TrkB). It is commonly referred to as CF3CN due to the CF3 and CN groups in its chemical structure, but this may cause confusion with the unrelated chemical trifluoroacetonitrile which has the chemical formula CF3CN. As with many TrkB agonists it was derived through modification of the natural product TrkB agonist 7,8-dihydroxyflavone, but it is more potent than earlier derivatives such as R13. It is under development as a potential treatment for neurodegenerative conditions such as Alzheimer's disease and Parkinson's disease.
=== Mechanism of action === Avasimibe is a potent activator of the pregnane X receptor and, consequently, an indirect inducer of CYP3A4 and P-glycoprotein, as well as a potent inhibitor of several cytochrome P450 isoenzymes, including CYP1A2, CYP2C9, and CYP2C19; its spectrum of CYP induction and inhibition is similar to that of rifampicin.
Sources: en.wikipedia.org
No single time applies to all peptides. Storage life depends on sequence, solvent, concentration, and temperature. Stability should be determined experimentally or taken from supplier data for the specific lot.
Refreezing is possible but repeated cycles are discouraged. Each freeze-thaw step may increase aggregation or loss. Aliquoting before freezing reduces the number of cycles.
Cloudiness, visible particles, color changes, or new peaks in chromatography can indicate degradation. A loss of expected activity in an assay may also suggest a problem. Confirmatory methods include LC-MS and purity analysis.
Storage time depends on peptide sequence, concentration, solvent, and temperature. No single shelf life applies to all peptides. Stability should be determined by analytical testing for the specific preparation.